A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home AIMD Business VeriTeQ Acquisition Corporation Acquires Implantable, FDA-Cleared VeriChip Technology
formats

VeriTeQ Acquisition Corporation Acquires Implantable, FDA-Cleared VeriChip Technology

 

VeriMed's Human-Implantable VeriChip RFID

Image Credit: VeriMed

On January 17, 2012, VeriTeQ Acquisition Corporation of Delray Beach, FL announced that it acquired the VeriChip implantable RFID technology and its related Health Link personal health record from PositiveID Corporation.

VeriTeQ Acquisition Corporation is a marketer of implantable, radio frequency identification technologies for patient identification and sensor applications.   VeriTeQ is majority owned and led by Scott R. Silverman, former Chairman and CEO of PositiveID and VeriChip Corporation. PositiveID has retained an ownership interest in VeriTeQ.

VeriTeQ will focus on patient identification and personal health record (PHR) access through the VeriChip implantable microchip and Health Link web-based PHR; implantable sensor applications; and identification of medical devices within the body. VeriTeQ will also focus on identification and sensor applications for veterinary applications.

VeriTeQ’s acquisition also includes the rights to a Development and Supply Agreement with Medical Components, Inc. (“Medcomp”), a leading manufacturer of vascular access catheters. Under the terms of the agreement, Medcomp will embed the VeriChip microchip in its vascular ports to facilitate identification of the port in a patient and proper medication dispensing.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on VeriTeQ Acquisition Corporation Acquires Implantable, FDA-Cleared VeriChip Technology  comments